A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice.
Vijay K SinghOluseyi O FatanmiStephen Y WiseAlana CarpenterSara Nakamura-PeekArtur A SerebrenikMichael D KaytorPublished in: International journal of radiation biology (2021)
Our results demonstrate that BIO 300 OP, which can be administered orally, is a promising prophylactic radiation countermeasure for H-ARS.